AzTrials
AzTrials

Periodontitis, AdultNCT03297749

Genetic Variants and Oxidative Stress as Links Between Periodontitis and Metabolic Syndrome

An observational study of Periodontitis, Adult and Metabolic Syndrome, run by University College, London at 2 sites in 2 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to investigate the systemic impact of periodontitis in patients with Metabolic Syndrome, by assessing measures of sub-clinical atherosclerosis and cardiovascular risk, microbial factors and host genetic variants, and to study the possible effect of mediators of inflammation and oxidative… Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Periodontitis, Adult, Metabolic Syndrome
How many people
102 participants
Where
2 sitesin 2 countries
Study dates
1 Jul 2015to 31 Dec 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Adult, Older adult

Study population: Subjects with metabolic syndrome will be recruited from outpatients attending the Internal Medicine Unity at the University of Catania.

Who may be able to join

  • Caucasian ethnicity
  • Age 18- 75
  • Diagnosis of metabolic syndrome
  • Presence of at least 12 teeth

Who cannot join

  • Pregnancy
  • Presence of infectious diseases such as hepatitis and HIV
  • Use of non-steroidal anti-inflammatory drugs (excluding low-dose aspirin) within one month prior to the baseline visit
  • Use of systemic antibiotics within three months prior to the baseline visit
  • Antibiotic pre-medication required for the performance of periodontal examination

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

Italy1 site
  • University of Catania

    Catania

Other trials in Italy

United Kingdom1 site
  • UCL

    London, EN54LU

Other trials in United Kingdom

About this study

The aim of this study is to investigate the systemic impact of periodontitis in patients with Metabolic Syndrome, by assessing measures of sub-clinical atherosclerosis and cardiovascular risk, microbial factors and host genetic variants, and to study the possible effect of mediators of inflammation and oxidative stress as links between the two conditions.

Read the detailed description

This is a cross-sectional study. 102 patients with metabolic syndrome will be recruited and will have periodontal and dental examination for diagnosis of caries and periodontal diseases. They will undergo blood, saliva, GCF and subgingival plaque sampling and a series of tests on cardiovascular disease, including measures of pulse-wave velocity,carotid intima-media thickness and echocardiography assessment. Statistical analysis will assess associations between dental diagnoses and metabolic, cardiovascular, inflammatory, genetic, microbial and cardiovascular risk outcomes.

Being tested
Observational study (no intervention)
Medical subject headings
Chronic Periodontitis, Metabolic Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Observational study (no intervention)Other

    Also called No interventions

    No interventions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pulse wave velocity

    Measured: baseline

  2. oxidative stress

    Measured: baseline

  3. carotid intima-media thickness

    Measured: baseline

  4. genetic variants

    Measured: baseline

  5. left ventricular mass

    Measured: baseline

Secondary outcomes (2)
  1. inflammatory markers

    Measured: baseline

  2. subgingival microbes

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Sep 2017
  2. Study start1 Jul 2015
  3. Primary completion30 Sep 2017
  4. Study completion31 Dec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
102 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03297749
Sponsor's protocol ID
4242/01
Status last verified
Sep 2017
First submitted
26 Sep 2017
Last updated
26 Oct 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Nibali L, Donos N, Terranova V, Di Pino A, Di Marca S, Ferrara V, Pisano M, Scicali R, Rabuazzo AM, Purrello F, Malatino L. Left ventricular geometry and periodontitis in patients with the metabolic syndrome. Clin Oral Investig. 2019 Jun;23(6):2695-2703. doi: 10.1007/s00784-018-2667-8. Epub 2018 Oct 22.

    PubMed 30350134

Questions about this trial

What is this clinical trial studying?

An observational study of Periodontitis, Adult and Metabolic Syndrome, run by University College, London at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Italy, United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pulse wave velocity (time frame: baseline). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03297749, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in